Ambu is cutting DKK 250m (USD 34m) from its annual costs, and this will help to ensure that the Danish medtech firm will not need to raise new capital to keep the gears turning, says CEO Britt Meelby Jensen.
She and CFO Thomas Frederik Schmidt explained the new cuts in an investor teleconference after a guidance downgrade and the new savings plan were revealed alongside Ambu’s key figures from April, May and June.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
ALK to exit Turkish market: "It's bad business if all we get is peanuts"
A number of conditions made it unfeasible for the Danish allergy firm to do business in Türkiye, says CEO Carsten Hellmann. Under a calculated and ruthless strategy to focus on markets with momentum, efforts in Italy and Spain have also been reduced.
Genmab postpones crucial cancer candidate decision following Abbvie exit
For the rest of 2022, the Danish biotech firm will share all expenses relating to the development of Duohexabody-CD37 with Abbvie, despite the US-based firm’s decision to withdraw from the collaboration in question.
Genmab says new arbitration builds on a straightforward question
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.
Top news from MedWatch this week
Miss anything?
Analyst: Upgraded ALK sales guidance could still be beaten
Despite an upgrade, ALK may still beat its own sales guidance, one Sydbank analyst predicts.
Medical Director 
Lead Automation Engineer ABB Sattline/ABB 800XA, AFRY 
Senior Manager, QA GCP/PV 
Senior CMC Regulatory Manage 
Senior Clinical Trial Manager - Black Swans Exist 
Clinical Trial Manager - Black Swans Exist 
Head of Regulatory Services Denmark 
Scientist Radiochemistry 
Quality coordinator for Aseptic Production, ALK 
Global Quality Director (Business Unit Quality Lead) 
Lead Auditor – Senior Quality Assurance Specialist 
GMP Compliance Consultant for Eltronic in Ballerup